Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-013145

Chief Executive Officer sold 5,675 shares at $224.23 ($1,272,526)

  • Chief Executive Officer acquired 5,675 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2023-04-17 Option exercise 10b5-1 +5,675 $57.76 $327,788 442,575 D
Farrell Michael J. Chief Executive Officer 2023-04-17 Sale 10b5-1 −5,675 $224.23 $1,272,526 436,900 D
Derivatives
Farrell Michael J. Chief Executive Officer 2023-04-17 Option exercise · ResMed Common Stock Options 10b5-1 −5,675 43,190 D
Open-market sales · 5,675 sh · avg $224.23 · $1,272,526
Loading xslF345X04/form4.xml…